Founder populations and their uses for breast cancer genetics

AUTOR(ES)

Neuhausen, Susan L

FONTE

BioMed Central

RESUMO

Numerous founder mutations have been reported in BRCA1 and BRCA2. For genetic screening of a population with a founder mutation, testing can be targeted to the mutation, allowing for a more rapid and less expensive test. In addition, more precise estimates of the prior probability of carrying a mutation and of the likelihood of a mutation carrier developing cancer should be possible. For a given founder mutation a large number of carriers are available, so that focused scientific studies of penetrance, expression, and genetic and environmental modifiers of risk can be performed. Finally, founder populations may be a powerful resource to localize additional breast cancer susceptibility loci, because of the reduction in locus heterogeneity.

Documentos Relacionados

• Prevalence and impact of founder mutations in hereditary breast cancer in Latin America
• ABC of breast diseases: Breast cancer—epidemiology, risk factors, and genetics
• Breast cancer, genetics, and age at first pregnancy.
• Familial Breast and Ovarian Cancer: Genetics, Screening and Management
• Molecular genetics of familial breast-ovarian cancer.